Restructuring the FDA's Food Program: Promises and Pitfalls

Sammer Marzouk; Kranti C Rumalla; Peter G Lurie

doi:10.3390/foods13203334

Restructuring the FDA's Food Program: Promises and Pitfalls

Foods. 2024 Oct 21;13(20):3334. doi: 10.3390/foods13203334.

Authors

Sammer Marzouk¹, Kranti C Rumalla¹, Peter G Lurie²

Affiliations

¹ Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA.
² Center for Science in the Public Interest, 1250 I Street NW, Suite 500, Washington, DC 20005, USA.

Abstract

Following an outbreak of Cronobacter sakazakii infection in infant formula, the US Food and Drug Administration commissioned a series of reports and then undertook a major reorganization of its food program. This article describes the changes that went into effect on 1 October 2024, why those changes are likely to improve the new Human Foods Program, and additional work that must be undertaken to enhance the agency's impact upon public health.

Keywords: Human Foods Program; US Food and Drug Administration; infant formula; public policy; regulation; reorganization.

Grants and funding

Supported by the Harvey Motulsky and Lisa Norton-Motulsky fund.